Smiths Medical, Inc., a prominent player in the medical device industry, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1940, the company has established itself as a leader in innovative medical solutions, particularly in the fields of infusion therapy, vascular access, and respiratory care. Smiths Medical is renowned for its core products, including advanced infusion pumps, safety-engineered devices, and airway management solutions, all designed to enhance patient safety and improve clinical outcomes. The company’s commitment to quality and innovation has positioned it as a trusted partner in healthcare, with notable achievements in developing cutting-edge technologies that meet the evolving needs of medical professionals.
How does Smiths Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Smiths Medical, Inc.'s score of 27 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Smiths Medical, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of ICU Medical, Inc., which may influence its climate commitments and emissions reporting. As of now, there are no documented reduction targets or initiatives outlined by Smiths Medical, indicating a potential area for future development in their sustainability strategy. Given the absence of specific emissions data and reduction initiatives, it is unclear how Smiths Medical aligns with industry standards for carbon reduction. The company may benefit from adopting frameworks such as the Science Based Targets initiative (SBTi) or participating in the Carbon Disclosure Project (CDP) to enhance its climate commitments and transparency. In summary, while Smiths Medical, Inc. has not disclosed specific emissions figures or reduction targets, its affiliation with ICU Medical, Inc. suggests potential for future alignment with broader corporate sustainability goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Smiths Medical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.